Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» Topsalysin
Topsalysin
Sophiris, Stock Sliding After Cancer Drug Data, Still Plans Phase 3
Xconomy
Mon, 12/17/18 - 08:18 pm
Sophris
prostate cancer
clinical trials
Topsalysin
Sophiris says it’s ready to get back on track with lead drug after patient death — but questions linger
Endpoints
Wed, 08/29/18 - 10:23 am
Sophris
Topsalysin
prostate cancer
Sudden death forces Sophiris to halt followup therapy in prostate cancer study — shares crushed
Endpoints
Mon, 06/25/18 - 12:47 pm
Sophris
prostate cancer
Topsalysin
clinical trials
Sophiris Bio: How Far Off Is Topsalysin's FDA Application?
Seeking Alpha
Tue, 10/11/16 - 09:41 am
Sophiris Bio
Topsalysin
FDA
prostate cancer